(Total Views: 586)
Posted On: 06/13/2018 1:24:40 PM
Post# of 1481
This ought to help the whole sector:
A Big Step Forward for Medical Marijuana
Jun 13, 2018
Medical marijuana has picked up considerable momentum after a U.S. Food and Drug Administration advisory panel unanimously recommended approval of GW Pharmaceuticals' epilepsy medication, Epidolex. The panel recommended approval of the drug to treat two forms of epilepsy -- Lennox-Gastaut syndrome and Dravet syndrome, which are the most difficult types of epilepsy to treat despite other currently available traditional medications. If the agency follows the recommendation, this would be the first cannabis-derived prescription medicine available in the U.S. and could be sold in the U.S. this year.
https://www.analyticalcannabis.com/news/a-big...ana-305007
$MYDX
A Big Step Forward for Medical Marijuana
Jun 13, 2018
Medical marijuana has picked up considerable momentum after a U.S. Food and Drug Administration advisory panel unanimously recommended approval of GW Pharmaceuticals' epilepsy medication, Epidolex. The panel recommended approval of the drug to treat two forms of epilepsy -- Lennox-Gastaut syndrome and Dravet syndrome, which are the most difficult types of epilepsy to treat despite other currently available traditional medications. If the agency follows the recommendation, this would be the first cannabis-derived prescription medicine available in the U.S. and could be sold in the U.S. this year.
https://www.analyticalcannabis.com/news/a-big...ana-305007
$MYDX
(0)
(0)
